Health

Results: 6529-6540 of 8109

PR Newswire associated0

Walden Group, one of the main players in European healthcare logistics, officially enters the Italian market

PR Newswire associated0

United Imaging Intelligence Unveiled Next-Generation Radiology Solutions at ECR 2024

Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients

GENESIS Pharma Announces an Exclusive Distribution Agreement With Regeneron Pharmaceuticals to Commercialize cemiplimab in Greece, Cyprus and Malta

'An Urgent Public Health Necessity' - National Institute for Play Releases New Report Underlining Science and Power of Play

STEMCELL Technologies is pleased to announce the acquisition of substantially all assets of SQZ Biotechnologies Company (SQZ)—a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them (mechanoporation) rather than using electricity (electroporation). This transaction, which was approved by SQZ shareholders on February 29, 2024, marks another significant milestone for STEMCELL, Canada’s largest biotechnology company. (Photo: Business Wire)

STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company

Sebia Receives U.S. FDA Clearance for the FLC Kappa & Lambda Assays

PR Newswire associated0

Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER

PR Newswire associated0

Oxehealth implements contactless patient monitoring solution at SummitStone Health Partners

Elsevier

Elsevier Health Launches ClinicalKey AI, the Most Advanced Gen AI-Powered Clinical Decision Support Tool for Clinicians

PR Newswire associated0

Alamar Biosciences and ALZpath, Inc. Announce Strategic Supply Agreement for pTau217 Antibody to Advance Alzheimer's Disease Research

Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations